ANI Pharmaceuticals Inc (NASDAQ:ANIP)

62.27
Delayed Data
As of May 25
 -0.67 / -1.06%
Today’s Change
42.23
Today|||52-Week Range
74.70
-3.38%
Year-to-Date
BioMarin's Palynziq Gets FDA Approval for Phenylketonuria
May 25 / Zacks.com - Paid Partner Content
Ligand Pharmaceuticals (LGND) Hits a 52-Week High, Can the Run Continue?
May 21 / Zacks.com - Paid Partner Content
INSYS Gets Negative FDA Recommendation for Pain Candidate
May 23 / Zacks.com - Paid Partner Content